Brian Clark McCarthy - 02 Aug 2024 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Revenue Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol
OPRX
Transactions as of
02 Aug 2024
Net transactions value
$0
Form type
4
Filing time
05 Aug 2024, 17:22:41 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Stock Option Award $0 +18,677 $0.000000 18,677 02 Aug 2024 Common Stock 18,677 $10.49 Direct F1
transaction OPRX Restricted Stock Units Award $0 +9,533 $0.000000 9,533 02 Aug 2024 Common Stock 9,533 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest 1/3 at the end of each anniversary from issuance.
F2 Each restricted stock unit represents a contingent right to receive one share of OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.